These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Intra-peritoneal and intra-rectal immunogenicity induced by rotavirus virus like particles 2/6/7 in mice. Marashi SM; Jalilvand S; Mollaei-Kandelous Y; Shahmahmoodi S; Rezaei F; Salimi V; Nejati A; Validi M; Shoja Z Microb Pathog; 2014; 67-68():48-54. PubMed ID: 24583154 [TBL] [Abstract][Full Text] [Related]
24. Rotavirus anti-VP6 secretory immunoglobulin A contributes to protection via intracellular neutralization but not via immune exclusion. Corthésy B; Benureau Y; Perrier C; Fourgeux C; Parez N; Greenberg H; Schwartz-Cornil I J Virol; 2006 Nov; 80(21):10692-9. PubMed ID: 16956954 [TBL] [Abstract][Full Text] [Related]
25. Distribution and phenotype of rotavirus-specific B cells induced during the antigen-driven primary response to 2/6 virus-like particles administered by the intrarectal and the intranasal routes. Di Martino C; Basset C; Ogier A; Charpilienne A; Poncet D; Kohli E J Leukoc Biol; 2007 Oct; 82(4):821-8. PubMed ID: 17652448 [TBL] [Abstract][Full Text] [Related]
26. Homotypic protection against rotavirus-induced diarrhea in infant mice breast-fed by dams immunized with the recombinant VP8* subunit of the VP4 capsid protein. Gil MT; de Souza CO; Asensi M; Buesa J Viral Immunol; 2000; 13(2):187-200. PubMed ID: 10892999 [TBL] [Abstract][Full Text] [Related]
27. Subunit Vaccine Preparation of Bovine Rotavirus and Its Efficacy in Mice. Suocheng W; Tuanjie C; Changjun S; Fengling T; Zhongren M Iran J Immunol; 2015 Sep; 12(3):188-97. PubMed ID: 26412637 [TBL] [Abstract][Full Text] [Related]
28. Recognition of rotavirus antigens by mouse L3T4-positive T helper cells. Bruce MG; Campbell I; Xiong Y; Redmond M; Snodgrass DR J Gen Virol; 1994 Aug; 75 ( Pt 8)():1859-66. PubMed ID: 8046388 [TBL] [Abstract][Full Text] [Related]
29. Bacterial expression of the major antigenic regions of porcine rotavirus VP7 induces a neutralizing immune response in mice. Wang L; Huang JA; Nagesha HS; Smith SC; Phelps A; Holmes I; Martyn JC; Coloe PJ; Reeves PR Vaccine; 1999 Jun; 17(20-21):2636-45. PubMed ID: 10418913 [TBL] [Abstract][Full Text] [Related]
30. Cross-linking of rotavirus outer capsid protein VP7 by antibodies or disulfides inhibits viral entry. Aoki ST; Trask SD; Coulson BS; Greenberg HB; Dormitzer PR; Harrison SC J Virol; 2011 Oct; 85(20):10509-17. PubMed ID: 21849465 [TBL] [Abstract][Full Text] [Related]
31. Immunogenicity and efficacy in mice of an adenovirus-based bicistronic rotavirus vaccine expressing NSP4 and VP7. Xie L; Yan M; Wang X; Ye J; Mi K; Yan S; Niu X; Li H; Sun M Virus Res; 2015 Dec; 210():298-307. PubMed ID: 26368053 [TBL] [Abstract][Full Text] [Related]
32. Human rotavirus VP6-specific antibodies mediate intracellular neutralization by binding to a quaternary structure in the transcriptional pore. Aiyegbo MS; Sapparapu G; Spiller BW; Eli IM; Williams DR; Kim R; Lee DE; Liu T; Li S; Woods VL; Nannemann DP; Meiler J; Stewart PL; Crowe JE PLoS One; 2013; 8(5):e61101. PubMed ID: 23671563 [TBL] [Abstract][Full Text] [Related]
33. Monoclonal antibodies directed against VP7 protein of human group B rotavirus. Deng X; Xiong G; Cong W; Liu Z; Qi C; Yang J Monoclon Antib Immunodiagn Immunother; 2014 Feb; 33(1):38-41. PubMed ID: 24555935 [TBL] [Abstract][Full Text] [Related]